You Zhi Tong
Chief Executive Officer bei KINTOR PHARMACEUTICAL LIMITED
Vermögen: 5 Mio $ am 31.03.2024
Profil
You Zhi Tong is the founder of Suzhou Kintor Pharmaceuticals, Inc. (founded in 2009) and Kintor Pharmaceutical Ltd.
(founded in 2009) where he held the titles of Chairman & Chief Executive Officer.
He also worked as a Vice President at Angion Biomedica Corp.
Dr. Tong received his undergraduate and graduate degrees from Peking University and his doctorate from Cornell University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.04.2024 | 41 004 770 ( 9,16% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von You Zhi Tong
| Unternehmen | Position | Beginn |
|---|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Chief Executive Officer | 24.03.2009 |
Suzhou Kintor Pharmaceuticals, Inc.
 Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von You Zhi Tong
| Unternehmen | Position | Ende |
|---|---|---|
| ANGN BIOM | Corporate Officer/Principal | - |
Ausbildung von You Zhi Tong
| Peking University | Graduate Degree |
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Health Technology |
